Skip to main content
Top
Published in: Archives of Virology 5/2018

01-05-2018 | Original Article

Genetic characterization and diversity of circulating influenza A/H1N1pdm09 viruses isolated in Jeddah, Saudi Arabia between 2014 and 2015

Authors: Anwar M. Hashem, Esam I. Azhar, Sarah Shalhoub, Turki S. Abujamel, Norah A. Othman, Abdulwahab B. Al Zahrani, Hanan M. Abdullah, Maha M. Al-Alawi, Anees A. Sindi

Published in: Archives of Virology | Issue 5/2018

Login to get access

Abstract

The emerged influenza A/H1N1pdm09 viruses have replaced the previously circulating seasonal H1N1 viruses. The close antigenic properties of these viruses to the 1918 H1N1 pandemic viruses and their post-pandemic evolution pattern could further enhance their adaptation and pathogenicity in humans representing a major public health threat. Given that data on the dynamics and evolution of these viruses in Saudi Arabia is sparse we investigated the genetic diversity of circulating influenza A/H1N1pdm09 viruses from Jeddah, Saudi Arabia, by analyzing 39 full genomes from isolates obtained between 2014-2015, from patients with varying symptoms. Phylogenetic analysis of all gene segments and concatenated genomes showed similar topologies and co-circulation of clades 6b, 6b.1 and 6b.2, with clade 6b.1 being the most predominate since 2015. Most viruses were more closely related to the vaccine strain (Michigan/45/2015) recommended for the 2017/2018 season, than to the California/07/2009 strain. Low sequence variability was observed in the haemagglutinin protein compared to the neuraminidase protein. Resistance to neuraminidase inhibitors was limited as only one isolate had the H275Y substitution. Interestingly, two isolates had short PA-X proteins of 206 amino acids compared to the 232 amino acid protein found in most influenza A/H1N1pdm09 viruses. Together, the co-circulation of several clades and the predominance of clade 6b.1, despite its low circulation in Asia in 2015, suggests multiple introductions most probably during the mass gathering events of Hajj and Umrah. Jeddah represents the main port of entry to the holy cities of Makkah and Al-Madinah, emphasizing the need for vigilant surveillance in the kingdom.
Appendix
Available only for authorised users
Literature
1.
go back to reference Medina RA, García-Sastre A (2011) Influenza A viruses: new research developments. Nat Rev Microbiol 9:590–603CrossRefPubMed Medina RA, García-Sastre A (2011) Influenza A viruses: new research developments. Nat Rev Microbiol 9:590–603CrossRefPubMed
2.
go back to reference Nguyen-Van-Tam JS, Hampson AW (2003) The epidemiology and clinical impact of pandemic influenza. Vaccine 21:1762–1768CrossRefPubMed Nguyen-Van-Tam JS, Hampson AW (2003) The epidemiology and clinical impact of pandemic influenza. Vaccine 21:1762–1768CrossRefPubMed
4.
go back to reference Lui KJ, Kendal AP (1987) Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 77:712–716CrossRefPubMedPubMedCentral Lui KJ, Kendal AP (1987) Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 77:712–716CrossRefPubMedPubMedCentral
7.
go back to reference Martinez O, Tsibane T, Basler CF (2009) Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery. Int Rev Immunol 28:69–92CrossRefPubMed Martinez O, Tsibane T, Basler CF (2009) Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery. Int Rev Immunol 28:69–92CrossRefPubMed
8.
go back to reference Schäfer JR, Kawaoka Y, Bean WJ et al (1993) Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology 194:781–788CrossRefPubMed Schäfer JR, Kawaoka Y, Bean WJ et al (1993) Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology 194:781–788CrossRefPubMed
10.
go back to reference Garten RJ, Davis CT, Russell CA et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201CrossRefPubMedPubMedCentral Garten RJ, Davis CT, Russell CA et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201CrossRefPubMedPubMedCentral
11.
12.
go back to reference Miller MA, Viboud C, Balinska M et al (2009) The signature features of influenza pandemics—implications for policy. N Engl J Med 360:2595–2598CrossRefPubMed Miller MA, Viboud C, Balinska M et al (2009) The signature features of influenza pandemics—implications for policy. N Engl J Med 360:2595–2598CrossRefPubMed
13.
go back to reference Smith GJ, Vijaykrishna D, Bahl J et al (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122–1125CrossRefPubMed Smith GJ, Vijaykrishna D, Bahl J et al (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122–1125CrossRefPubMed
14.
15.
go back to reference Cutler J, Schleihauf E, Hatchette TF et al (2009) Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ 181:159–163CrossRefPubMedPubMedCentral Cutler J, Schleihauf E, Hatchette TF et al (2009) Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ 181:159–163CrossRefPubMedPubMedCentral
16.
go back to reference Fisman DN, Savage R, Gubbay J et al (2009) Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 361:2000–2001CrossRefPubMed Fisman DN, Savage R, Gubbay J et al (2009) Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 361:2000–2001CrossRefPubMed
17.
go back to reference Hancock K, Veguilla V, Lu X et al (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361:1945–1952CrossRefPubMed Hancock K, Veguilla V, Lu X et al (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361:1945–1952CrossRefPubMed
18.
go back to reference Dorigatti I, Cauchemez S, Ferguson NM (2013) Increased transmissibility explains the third wave of infection by the 2009 H1N1 pandemic virus in England. Proc Natl Acad Sci USA 110:13422–13427CrossRefPubMedPubMedCentral Dorigatti I, Cauchemez S, Ferguson NM (2013) Increased transmissibility explains the third wave of infection by the 2009 H1N1 pandemic virus in England. Proc Natl Acad Sci USA 110:13422–13427CrossRefPubMedPubMedCentral
19.
go back to reference Otte A, Sauter M, Daxer MA et al (2015) Adaptive mutations that occurred during circulation in humans of H1N1 influenza virus in the 2009 pandemic enhance virulence in mice. J Virol 89:7329–7337CrossRefPubMedPubMedCentral Otte A, Sauter M, Daxer MA et al (2015) Adaptive mutations that occurred during circulation in humans of H1N1 influenza virus in the 2009 pandemic enhance virulence in mice. J Virol 89:7329–7337CrossRefPubMedPubMedCentral
20.
go back to reference Dong G, Peng C, Luo J et al (2015) Adamantane-resistant influenza A viruses in the world (1902–2013): frequency and distribution of M2 gene mutations. PLoS One 10:e0119115CrossRefPubMedPubMedCentral Dong G, Peng C, Luo J et al (2015) Adamantane-resistant influenza A viruses in the world (1902–2013): frequency and distribution of M2 gene mutations. PLoS One 10:e0119115CrossRefPubMedPubMedCentral
21.
22.
go back to reference Benkouiten S, Charrel R, Belhouchat K et al (2014) Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis 20:1821–1827CrossRefPubMedPubMedCentral Benkouiten S, Charrel R, Belhouchat K et al (2014) Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis 20:1821–1827CrossRefPubMedPubMedCentral
23.
go back to reference Memish ZA, Assiri A, Turkestani A et al (2015) Mass gathering and globalization of respiratory pathogens during the 2013 Hajj. Clin Microbiol Infect 21:571.e571–571.e578 Memish ZA, Assiri A, Turkestani A et al (2015) Mass gathering and globalization of respiratory pathogens during the 2013 Hajj. Clin Microbiol Infect 21:571.e571–571.e578
24.
go back to reference Tolah AM, Azhar EI, Hashem AM (2016) Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors. Saudi Med J 37:461–465CrossRefPubMedPubMedCentral Tolah AM, Azhar EI, Hashem AM (2016) Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors. Saudi Med J 37:461–465CrossRefPubMedPubMedCentral
26.
go back to reference Al-Saeed MS, El-Kafrawy SA, Farraj SA et al (2017) Phylogenetic characterization of circulating Dengue and Alkhumra Hemorrhagic Fever viruses in western Saudi Arabia and lack of evidence of Zika virus in the region: a retrospective study, 2010–2015. J Med Virol 89:1339–1346CrossRefPubMed Al-Saeed MS, El-Kafrawy SA, Farraj SA et al (2017) Phylogenetic characterization of circulating Dengue and Alkhumra Hemorrhagic Fever viruses in western Saudi Arabia and lack of evidence of Zika virus in the region: a retrospective study, 2010–2015. J Med Virol 89:1339–1346CrossRefPubMed
28.
go back to reference Kearse M, Moir R, Wilson A et al (2012) Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647–1649CrossRefPubMedPubMedCentral Kearse M, Moir R, Wilson A et al (2012) Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647–1649CrossRefPubMedPubMedCentral
30.
go back to reference Tamura K (1992) Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G + C-content biases. Mol Biol Evol 9:678–687PubMed Tamura K (1992) Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G + C-content biases. Mol Biol Evol 9:678–687PubMed
31.
go back to reference Kimura M (1980) A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120CrossRefPubMed Kimura M (1980) A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120CrossRefPubMed
32.
go back to reference Hasegawa M, Kishino H, Yano T (1985) Dating the human-ape split by a molecular clock of mitochondrial DNA. J Mol Evol 22:160–174CrossRefPubMed Hasegawa M, Kishino H, Yano T (1985) Dating the human-ape split by a molecular clock of mitochondrial DNA. J Mol Evol 22:160–174CrossRefPubMed
33.
go back to reference Nei M, Kumar S (2000) Molecular evolution and phylogenetics. Oxford University Press, New York Nei M, Kumar S (2000) Molecular evolution and phylogenetics. Oxford University Press, New York
34.
go back to reference Houng HS, Garner J, Zhou Y et al (2012) Emergent 2009 influenza A(H1N1) viruses containing HA D222N mutation associated with severe clinical outcomes in the Americas. J Clin Virol 53:12–15CrossRefPubMed Houng HS, Garner J, Zhou Y et al (2012) Emergent 2009 influenza A(H1N1) viruses containing HA D222N mutation associated with severe clinical outcomes in the Americas. J Clin Virol 53:12–15CrossRefPubMed
35.
go back to reference Nguyen HK, Nguyen PT, Nguyen TC et al (2015) Virological characterization of influenza H1N1pdm09 in Vietnam, 2010–2013. Influenza Other Respir Viruses 9:216–224CrossRefPubMedPubMedCentral Nguyen HK, Nguyen PT, Nguyen TC et al (2015) Virological characterization of influenza H1N1pdm09 in Vietnam, 2010–2013. Influenza Other Respir Viruses 9:216–224CrossRefPubMedPubMedCentral
36.
go back to reference Parida M, Dash PK, Kumar JS et al (2016) Emergence of influenza A(H1N1)pdm09 genogroup 6B and drug resistant virus, India, January to May 2015. Euro Surveill 21:6–11CrossRefPubMed Parida M, Dash PK, Kumar JS et al (2016) Emergence of influenza A(H1N1)pdm09 genogroup 6B and drug resistant virus, India, January to May 2015. Euro Surveill 21:6–11CrossRefPubMed
37.
go back to reference Wedde M, Biere B, Wolff T et al (2015) Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008–2009 and 2013–2014 in Germany. Int J Med Microbiol 305:762–775CrossRefPubMed Wedde M, Biere B, Wolff T et al (2015) Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008–2009 and 2013–2014 in Germany. Int J Med Microbiol 305:762–775CrossRefPubMed
43.
go back to reference Al-Qahtani AA, Mubin M, Dela Cruz DM et al (2017) Phylogenetic and nucleotide sequence analysis of influenza A (H1N1) HA and NA genes of strains isolated from Saudi Arabia. J Infect Dev Ctries 11:81–88CrossRefPubMed Al-Qahtani AA, Mubin M, Dela Cruz DM et al (2017) Phylogenetic and nucleotide sequence analysis of influenza A (H1N1) HA and NA genes of strains isolated from Saudi Arabia. J Infect Dev Ctries 11:81–88CrossRefPubMed
46.
go back to reference Hurt AC, Leang SK, Speers DJ et al (2012) Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses. Emerg Infect Dis 18:109–112CrossRefPubMedPubMedCentral Hurt AC, Leang SK, Speers DJ et al (2012) Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses. Emerg Infect Dis 18:109–112CrossRefPubMedPubMedCentral
47.
go back to reference Kong W, Liu L, Wang Y et al (2014) Hemagglutinin mutation D222N of the 2009 pandemic H1N1 influenza virus alters receptor specificity without affecting virulence in mice. Virus Res 189:79–86CrossRefPubMed Kong W, Liu L, Wang Y et al (2014) Hemagglutinin mutation D222N of the 2009 pandemic H1N1 influenza virus alters receptor specificity without affecting virulence in mice. Virus Res 189:79–86CrossRefPubMed
48.
go back to reference Matos-Patrón A, Byrd-Leotis L, Steinhauer DA et al (2015) Amino acid substitution D222N from fatal influenza infection affects receptor-binding properties of the influenza A(H1N1)pdm09 virus. Virology 484:15–21CrossRefPubMed Matos-Patrón A, Byrd-Leotis L, Steinhauer DA et al (2015) Amino acid substitution D222N from fatal influenza infection affects receptor-binding properties of the influenza A(H1N1)pdm09 virus. Virology 484:15–21CrossRefPubMed
49.
go back to reference Goka EA, Vallely PJ, Mutton KJ et al (2014) Mutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: a systematic review and meta-analysis of epidemiological evidence. Arch Virol 159:3167–3183CrossRefPubMed Goka EA, Vallely PJ, Mutton KJ et al (2014) Mutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: a systematic review and meta-analysis of epidemiological evidence. Arch Virol 159:3167–3183CrossRefPubMed
50.
go back to reference Jagger BW, Wise HM, Kash JC et al (2012) An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337:199–204CrossRefPubMedPubMedCentral Jagger BW, Wise HM, Kash JC et al (2012) An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337:199–204CrossRefPubMedPubMedCentral
52.
go back to reference Shi M, Jagger BW, Wise HM et al (2012) Evolutionary conservation of the PA-X open reading frame in segment 3 of influenza A virus. J Virol 86:12411–12413CrossRefPubMedPubMedCentral Shi M, Jagger BW, Wise HM et al (2012) Evolutionary conservation of the PA-X open reading frame in segment 3 of influenza A virus. J Virol 86:12411–12413CrossRefPubMedPubMedCentral
53.
go back to reference Kosik I, Holly J, Russ G (2013) PB1-F2 expedition from the whole protein through the domain to aa residue function. Acta Virol 57:138–148CrossRefPubMed Kosik I, Holly J, Russ G (2013) PB1-F2 expedition from the whole protein through the domain to aa residue function. Acta Virol 57:138–148CrossRefPubMed
54.
go back to reference Hayashi T, MacDonald LA, Takimoto T (2015) Influenza A virus protein PA-X contributes to viral growth and suppression of the host antiviral and immune responses. J Virol 89:6442–6452CrossRefPubMedPubMedCentral Hayashi T, MacDonald LA, Takimoto T (2015) Influenza A virus protein PA-X contributes to viral growth and suppression of the host antiviral and immune responses. J Virol 89:6442–6452CrossRefPubMedPubMedCentral
55.
go back to reference Bavagnoli L, Cucuzza S, Campanini G et al (2015) The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA. Nucleic Acids Res 43:9405–9417CrossRefPubMedPubMedCentral Bavagnoli L, Cucuzza S, Campanini G et al (2015) The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA. Nucleic Acids Res 43:9405–9417CrossRefPubMedPubMedCentral
56.
go back to reference Gao H, Sun H, Hu J et al (2015) Twenty amino acids at the C-terminus of PA-X are associated with increased influenza A virus replication and pathogenicity. J Gen Virol 96:2036–2049CrossRefPubMedPubMedCentral Gao H, Sun H, Hu J et al (2015) Twenty amino acids at the C-terminus of PA-X are associated with increased influenza A virus replication and pathogenicity. J Gen Virol 96:2036–2049CrossRefPubMedPubMedCentral
57.
go back to reference Xu G, Zhang X, Sun Y et al (2016) Truncation of C-terminal 20 amino acids in PA-X contributes to adaptation of swine influenza virus in pigs. Sci Rep 6:21845CrossRefPubMedPubMedCentral Xu G, Zhang X, Sun Y et al (2016) Truncation of C-terminal 20 amino acids in PA-X contributes to adaptation of swine influenza virus in pigs. Sci Rep 6:21845CrossRefPubMedPubMedCentral
58.
go back to reference Lee J, Yu H, Li Y et al (2017) Impacts of different expressions of PA-X protein on 2009 pandemic H1N1 virus replication, pathogenicity and host immune responses. Virology 504:25–35CrossRefPubMedPubMedCentral Lee J, Yu H, Li Y et al (2017) Impacts of different expressions of PA-X protein on 2009 pandemic H1N1 virus replication, pathogenicity and host immune responses. Virology 504:25–35CrossRefPubMedPubMedCentral
59.
go back to reference Trifonov V, Racaniello V, Rabadan R (2009) The contribution of the PB1-F2 protein to the fitness of influenza A viruses and its recent evolution in the 2009 influenza A (H1N1) pandemic virus. PLoS Curr 1:RRN1006CrossRefPubMedPubMedCentral Trifonov V, Racaniello V, Rabadan R (2009) The contribution of the PB1-F2 protein to the fitness of influenza A viruses and its recent evolution in the 2009 influenza A (H1N1) pandemic virus. PLoS Curr 1:RRN1006CrossRefPubMedPubMedCentral
Metadata
Title
Genetic characterization and diversity of circulating influenza A/H1N1pdm09 viruses isolated in Jeddah, Saudi Arabia between 2014 and 2015
Authors
Anwar M. Hashem
Esam I. Azhar
Sarah Shalhoub
Turki S. Abujamel
Norah A. Othman
Abdulwahab B. Al Zahrani
Hanan M. Abdullah
Maha M. Al-Alawi
Anees A. Sindi
Publication date
01-05-2018
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 5/2018
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-018-3732-y

Other articles of this Issue 5/2018

Archives of Virology 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.